May 2012 to 2000 Contractor/ConsultantKum and Go West Des Moines, IA Jun 2009 to Apr 2012 Sales ManagerKrieger's Hometown Sports Grill West Des Moines, IA Jun 2005 to May 2009 Owner/Operating ManagerRiverlanes Bowling Center Tulsa, OK Aug 2000 to 2005 Bar Manager
Now Jeff, who for the past year has been telling his story to Scott Monroe of the Kennebec Journal/Morning Sentinel, is among the first group of survivors to experience COVID-related problems well after they supposedly recover.
udy found the VTE risk was significantly greater with Ortho Evra than with lower-estrogen birth control pills.The black box warning was meant to draw more attention to the risk of blood clots, according to Scott Monroe, MD, director of the FDA's Division of Reproductive and Urologic Products.
Date: Dec 10, 2011
Category: Health
Source: Google
Birth Control Patch Should Stay on Market, Panel Says
The black box was not in response to new safety data emerging, but rather was meant to draw more attention to the risk of blood clots, said Scott Monroe, MD, director of the FDA's Division of Reproductive and Urologic Products.
Date: Dec 09, 2011
Category: Health
Source: Google
FDA Approves Cialis to Treat Benign Prostatic Hyperplasia
"BPH can have a big impact on a patient's quality of life," said Scott Monroe, director of the Division of Reproductive and Urologic Products in the FDA's Center for Drug Evaluation and Research. "A large number of older men have symptoms of BPH. Cialis offers these men another treatment option, par
Date: Oct 07, 2011
Category: Health
Source: Google
Benign Prostatic Hyperplasia Drug Cialis Approved By FDA
According to Scott Monroe, director of the Division of Reproductive and Urologic Products in the Center for Drug Evaluation and Research in the FDA, BPH can have a large impact on ones life.
Date: Oct 07, 2011
Category: Health
Source: Google
FDA: Drug Used to Prevent Premature Labor Dangerous for Moms-to-Be
"Women should be aware that serious and sometimes fatal side effects have been reported after prolonged use of terbutaline in pregnant women," said Dr. Scott Monroe, director of FDA's Division of Reproductive and Urologic Products, in a statement. "It is important for patients and health-care profes